We value your privacy

We use cookies to analyze site usage and improve your experience. You can accept all, reject non-essential, or customize. See our Privacy Policy.

Adaptogens

Ashwagandha in menopause

300–600mg KSM-66 shows modest cortisol reduction and sleep benefits.

Written by the Kindr Health Editorial & Clinical TeamMedically reviewed by Kindr Health Clinical Team NPI 1609792902Published Last reviewed

Key points

  • KSM-66 studied
  • Avoid with hyperthyroid
  • Cycle usage

Frequently asked questions

Thyroid safe?

Can push thyroid up — caution with hyperthyroidism.

Long-term?

Data limited beyond 12 weeks.

Considering a physician-supervised longevity protocol? Kindr Health evaluates peptide therapy as part of personalized perimenopause and menopause care.

Request your Longevity Consult →

Explore Kindr Health

HRT Hub →
Estrogen, progesterone, testosterone protocols
34 Symptoms →
The complete symptom index
Care Near Me →
Find menopause care in your city
Browse by State →
Licensed clinicians in all 50 states
Kindr Journal →
Evidence-based menopause reporting
Editorial Team →
Who reviews Kindr clinical content

Related: FDA peptide review July 2026 briefing · Peptide therapy hub · Longevity service

Written and medically reviewed by the Kindr Health Clinical Team · Published 2026-06-19 · Last reviewed 2026-07-01. Compounded medications are prepared by FDA-registered 503A pharmacies and are not FDA-approved drug products.